We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Stockholm, Sweden

ESTRO 2026

Session

Lung
Digital Poster
Clinical
The prognostic value of NTR SUV max and its correlation with NLR in patients with NSCLC treated with CCRT
Kiril Zhelev, Bulgaria
-23
Assessing Radiation Pneumonitis Risks Using Fractal Analyses in NSCLC Patients Treated with Curative-Intent Radiotherapy
Hakyoung Kim, Korea Republic of
-43
Prophylactic cranial irradiation versus active surveillance in limited-stage small cell lung cancer: a 10-year retrospective analysis
Mohammad Rafiqul Islam, United Kingdom
-104
Improving patient pathways to accessing the PACIFIC regimen
Connie Le, Canada
-105
Local Control Rates and Side Effects in Malignant Pleural Mesothelioma Treated with Intensity-Modulated Radiotherapy After Pleural Decortication
Fatma Sert, Turkey
-186
High-dose Radiation Therapy for Limited-Stage Small-Cell Lung Cancer: Real-World Experience from Two Tertiary Centers
Bilal Krayim, Israel
-194
Artificial Intelligence-Assisted Decision Making in Malignant Pleural Mesothelioma: A Comparative Analysis of AI Responses
Fatma Sert, Turkey
-224
Induction Immunochemotherapy Followed by Definitive Radiotherapy for Unresectable Locally Advanced NSCLC: A Real-World Observational Study
QIFENG WANG, China
-366
End-to-end genomic test turnaround times in non-small cell lung cancer across NHS hospitals in the East of England
Emily Scott, United Kingdom
-569
Safety and efficacy of stereotactic ablative radiotherapy in combination with Tarlatamab in patients with ES-SCLC: a case series.
donatella caivano, Italy
-627
Improving access and outcomes: Single-fraction SBRT for lung tumors in a dispersed aging population
Joaquín Cabrera Rodríguez, Spain
-724
Patterns of practice in thoracic reirradiation in Ontario: a department-level survey
Geraldine Murphy, Canada
-850
Radiation induced in situ pulmonary artery thrombosis in non-small cell lung cancer: A 10-year experience at a tertiary referral center in Thailand
Napat Aksornprom, Thailand
-1420
The prognostic value of methylated ctDNA, soluble PD-L1, and NK-cell activity on the risk of relapse after curative radiotherapy of NSCLC.
Thomas Leth Fink, Denmark
-1458
anatomic uncertainty in deep inspiration breath hold radiotherapy for lung tumor treatments monitored by external surrogates
Weixing Cai, USA
-1628
Supporting Informed Decision-Making in Small Cell Lung Cancer: An Environmental Scan on Prophylactic Cranial Irradiation Information Provision
Katie Dixon, United Kingdom
-1886
Development of A Co-designed ePROMs-Integrated Review Pathway During Lung Cancer Radiotherapy.
Hebatalla Abdelaal, United Kingdom
-1989
Adjuvant Thoracic Radiotherapy After Induction Chemoimmunotherapy and Surgery in Locally Advanced NSCLC: Failure Patterns and Safety
Merve Duman, Turkey
-1990
Chest wall adverse events following stereotactic body radiotherapy in peripheral lung tumors: incidence and dosimetric factors
Alexandra Giraldo Marin, Spain
-2042
Safety and efficacy of concurrent radiotherapy with amivantamab in patients with advanced EGFR- or MET-alterered non-small cell lung cancer
Antonin Levy, France
-2102
Failure Patterns After Induction Chemoimmunotherapy and Definitive Hypofractionated Thoracic Radiotherapy in Inoperable Locally Advanced NSCLC
Merve Duman, Turkey
-2119
Prognostic factors and survival in early stage lung SABR; a single centre UK experience
Will Barnsley, United Kingdom
-2163
Single-Fraction Stereotactic Body Radiotherapy for Localized Non-Small Cell Lung Cancer: Real-World Clinical Outcomes
João Basílio, Portugal
-2516
Early post-SBRT CT patterns and dosimetric factors predict recurrence in solitary lung nodules
MARÍA PAGOLA DIVASSÓN, Spain
-2528
circulating cell-free DNA as a predictive biomarker of cardiac adverse events in NSCLC patients treated with concurrent chemoradiotherapy
Ting Xu, USA
-2579
Lower BED SBRT in Frail Patients with Recurrent Lung-Only Metastases: Comparable Control, Reduced Toxicity
Ismaell Massalha, Israel
-2580
Lessons learned in SBRT practice for early-stage Non-Small cell Lung Cancer – Experience of a Tertiary Cancer Centre of India
JAI PRAKASH AGARWAL, India
-2586
STEREOTACTIC BODY RADIOTHERAPY FOR LUNG OLIGO-METASTASES: INSIGHTS FROM A MULTI-INSTITUTIONAL EXPERIENCE
Andrea D'Aviero, Italy
-2686
Minimizing Esophagitis in Locoregionally Advanced NSCLC Receiving Consolidation Hypofractionated Thoracic Radiotherapy Following Chemoimmunotherapy
Ugur Selek, Turkey
-2721
Role of right-lower-lobe-specific DVH parameters in predicting radiation pneumonitis risk after definitive radiation therapy for lung cancer
SACHIKO MIURA, Japan
-2862
Single-fraction SBRT with Radixact for lung malignancies: early outcomes of a single-center experience
Francesco Cuccia, Italy
-2881
Radiotherapy and immunotherapy for unresectable locally advanced non-small cell lung cancer: A systematic review from the Y-ECI ROSC EORTC Group.
Jonas Willmann, Switzerland
-3039
Prediction and related genes of distant metastasis of lung adenocarcinoma based on deep learning
ChunMei Xia, China
-3053
InDuRanS: Randomized trial on induction immunochemotherapy followed by surgery or chemoradiation and consolidation durvalumab in stage III NSCLC
Eleni Gkika, Germany
-3215
Long-term outcomes and patterns of failure after empiric SBRT for presumed early-stage lung tumors
Chukwuka Eze, Germany
-3400
Consolidative Thoracic Radiotherapy and Immunotherapy Following Induction Chemo-Immunotherapy in Locally Advanced and Oligometastatic NSCLC
Carlo Greco, Italy
-3467
Unravelling the interplay of diabetes, medication, and cardiac dose for predicting cardiovascular events after lung cancer radiotherapy.
Angela Davey, United Kingdom
-3493
SIRP?1 insertion exposes a prognostic immunogenomic vulnerability in small-cell lung cancer
Elias Gomis Selles, Spain
-3518
Contralateral Hilar Irradiation in Lung Cancer: A Systematic Review
Shigeo TAKAHASHI, Japan
-3593
Establishing a Credentialing Framework for Functional Lung-Sparing Radiotherapy Planning in the Phase III TROG 21.08 VITaL Clinical Trial
Guneet Kaur , Australia
-3628
Correlation between PD-L1 expression and prognosis in early-stage NSCLC treated with stereotactic ablative radiotherapy: a preliminary report
Jessica Saddi, Italy
-3674
Impact of Lymphopenia on Treatment Outcomes in Limited-Stage Small Cell Lung Cancer treated with definitive chemo-radiotherapy
Salvatore Cozzi, Italy
-3876
Predicting tumour regression in advance of RT: training and external testing of the Proliferation Saturation Index mathematical model in NSCLC
Sarah Barrett, Ireland
-4024
Cardiac dose and survival outcomes following SBRT for primary and metastatic lung tumors: a substructure-based analysis
Goda Kalinauskaite, Germany
-4092
Analysis of 58 patients referred to MRI-guided stereotactic radiation therapy for lung tumors
Kukka Heiskala , Finland
-4118
Manual coronary artery segmentation on 4-dimensional radiotherapy planning scans: old dogs can learn new tricks!
Andrew Walker, United Kingdom
-4149
GTV-based prescription in lung SBRT: Tumour dose consistency and local control in a single-institution interim analysis
Volha Hertsyk, Belgium
-4179
Thoracic Re-Irradiation: An 8-year safety review to inform modern practice
Gemma Wheeler, Ireland
-4182
Radiologic and metabolic tumor responses in patients with limited disease small cell lung cancer – prognostic potential
Sara Linde, Denmark
-4200
Emerging thoracic AI auto-segmented normal tissues and their potential role as new organs at risk (OARs) in lung cancer radiotherapy (RT)
Maria Thor, USA
-4229
Expanding the use of 60 Gy in 8 fractions SBRT in Central and Peripheral Lung Tumors: Results from a Single Tertiary Care Institution
Racha Khodor, Lebanon
-4309
Overall survival following palliative radiotherapy for catastrophic malignant airway events
Aly Muhammad Ladak, Canada
-4316
Impact of breathing motion on a novel artificial intelligence model used to screen treatment planning imaging for interstitial lung disease (ILD)
Andrew Hope, Canada
-4493
Re-irradiation with overlapping fields in previously irradiated early-stage lung cancer: Modern techniques, modest adverse events
Pantea Bayatfard, Turkey
-4538
Older Adults and Real-World Representation in SABR Lung Cancer Studies: Insights to date from the CTRIAL-IE 18-33 SOURCE Study.
Roisin O Maolalai, Ireland
-4574
Adaptive radiotherapy in locally advanced lung cancer: What is the benefit?
Nabila SELLAL, Morocco
-4590
Three-Dimensional Evaluation of Lung Displacement: Implications for Plan Uncertainty Calculation in Lung Radiotherapy
Abel Rodriguez Aranda, Spain
-4613
Role of Radiotherapy Approach, Molecular Profile, Time to CNS Involvement and Systemic Treatment as Predictors of NSCLC Brain Metastases Outcomes
Nikolay Tolev, Bulgaria
-4774
Tumor infiltrating lymphocyte is associated with favorable outcome in resectable non-small cell lung cancer treated with neoadjuvant chemoradiotherapy
Gabriela Oses, Spain
-5054
Feasibility of radical reirradiation of lung tumors in patients with previous breast radiotherapy
Cæcilie Ottosen, Denmark
-5113